AI Reshapes Initial Contact Point for Healthcare Inquiries
A discussion in Germany focused on how artificial intelligence is altering patient health searches, prompting a need for adaptation among healthcare providers.
Munich – Artificial intelligence (AI) is increasingly becoming the primary channel for health-related questions, transforming patient journeys and compelling pharmaceutical companies, pharmacies, physicians, and technology providers to redefine their roles. According to Pharma Deutschland e.V., a key challenge is integrating digital guidance, scientific evidence, and personal advice into a reliable healthcare chain.
The event on September 14, 2026, brought together experts to discuss AI's impact on patient behavior in healthcare. As large language models become more prevalent, individuals are increasingly using AI systems to seek information, prepare for doctor visits, and make health decisions. This shift highlights the demand for swift, clear, and personalized responses that align with consumer expectations from other aspects of life.
Patients' expectations for seamless communication and digital services often clash with outdated systems in daily healthcare. AI is reshaping the patient journey, leading individuals to pharmacies or doctor's offices with prior information and potentially AI-formulated options. The quality and reliability of this information are therefore critical.
Pharmaceutical companies must now consider how to ensure that scientifically sound information is accurately represented in AI responses. This necessitates a new form of "AI visibility" based on robust, structured, and machine-readable data. The pharmaceutical industry must evolve from merely providing products to curating trustworthy health knowledge, requiring close collaboration with regulatory bodies, the scientific community, and technology sector.